28 May 2026 Healthcare Stocks Small Caps Stocks Acrux (ASX:ACR) shares double as it banks A$5.4m from an amendment to its licensing deal for Lenzetto! Acrux (ASX:ACR) signs A$5.4m Lenzetto licensing amendment with Gedeon Richter, bringing the Estradiol spray to Australia’s short MHT market. ByCharlie Youlden
04 May 2026 Biotech Stocks Growth Stocks Healthcare Stocks Life Sciences Here Are 5 Of The Biggest ASX Biotech Success Stories! And 5 Of The Biggest Disasters! For every one of the ASX Biotech Success Stories, there are several failures. While a handful of companies can and do convert clinical data into extraordinary value, many others run… ByNick Sundich